Cargando…
Proteomics to study cancer immunity and improve treatment
Cancer survival and progression depend on the ability of tumor cells to avoid immune recognition. Advances in the understanding of cancer immunity and tumor immune escape mechanisms enabled the development of immunotherapeutic approaches. In patients with otherwise incurable metastatic cancers, immu...
Autores principales: | Franciosa, Giulia, Kverneland, Anders H., Jensen, Agnete W. P., Donia, Marco, Olsen, Jesper V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10121539/ https://www.ncbi.nlm.nih.gov/pubmed/36598558 http://dx.doi.org/10.1007/s00281-022-00980-2 |
Ejemplares similares
-
Impact of SHP2 tyrosine phosphorylation on the development of acquired resistance to allosteric SHP2 inhibitors
por: Franciosa, Giulia, et al.
Publicado: (2023) -
Proteomics of resistance to Notch1 inhibition in acute lymphoblastic leukemia reveals targetable kinase signatures
por: Franciosa, Giulia, et al.
Publicado: (2021) -
ProAlanase is an Effective Alternative to Trypsin for Proteomics Applications and Disulfide Bond Mapping
por: Samodova, Diana, et al.
Publicado: (2020) -
Development of anti-drug antibodies is associated with shortened survival in patients with metastatic melanoma treated with ipilimumab
por: Kverneland, Anders H., et al.
Publicado: (2018) -
Highly efficient PD-1-targeted CRISPR-Cas9 for tumor-infiltrating lymphocyte-based adoptive T cell therapy
por: Chamberlain, Christopher Aled, et al.
Publicado: (2022)